As Ebola Spreads in Two More Provinces, NanoViricides Has Received National Ethics Committee Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in Congo

SHELTON, CT /ACCESS Newswire/ July 13, 2026 /NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that it has received National Ethics Committee approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for the Current Bundibugyo Ebolavirus in the Democratic Republic of Congo (DRC). The Company is now getting ready...
Anglais

Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia Telangiectasia (A-T)

Niagen Bioscience, Inc.(NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that the U.S. Food & Drug Administration (FDA) granted Rare Pediatric Disease (RPD) Designation for its proprietary lead small molecule drug candidate NB4168 for the treatment of Ataxia Telangiectasia (A-T). NB4168 is an oral small molecule therapy engineered to deliver substantially greater nicotinamide riboside (NR) exposure than conventional NR while maintaining a differentiated pharmacokinetic and safety profile. In addition, the European Medicines Agency (EMA) has granted Orphan Medicinal Product Designation (OMPD) to NB4168 for the...
Anglais

CoTec to Host July 2026 Business Update Webinar

VANCOUVER, BC /ACCESS Newswire/ July 23, 2026 /CoTec Holdings Corp. (TSX-V:CTH)(OTCQX:CTHCF) ("CoTec" or the "Company") is pleased to announce that the Company's Chief Executive Officer, Julian Treger, and Chief Financial Officer, Braam Jonker will host an investor update onThursday, July 30...
Anglais

AHF at AIDS 2026 Conference: AIDS Isn't Over­—and Syphilis Is Surging

As a global leader in HIV and STI prevention and treatment, AIDS Healthcare Foundation (AHF) is once again bringing a bold and provocative message to the 26th International AIDS Conference (AIDS 2026) in Rio de Janeiro, Brazil, being held in person and virtually July 26-31. The risk and urgency of skyrocketing syphilis rates will be front and center at AHF's...
Anglais

GoodVision AI to Build 100 MW AI Factory in Japan via Strategic Partnership with AI Storm

GoodVision AI (“GoodVision”), a developer of next-generation AI compute infrastructure purpose-built for inference, today announced the establishment of its first next-generation AI Factory in Japan following the signing of a strategic cooperation agreement with AI Storm Co., Ltd. (Tokyo Stock Exchange: 3719) (“AI Storm”), a Japan-based business and IT consulting company...
Anglais

FlexTrade Expands Portfolio Risk and Analytics Capabilities Through Strategic Partnership with Portx

FlexTrade Systems(@FlexTrade), a global leader in multi-asset execution and order management systems, and Portx, an advanced portfolio construction and analytics provider, today announced the integration of Portx’sreal-time portfolio construction, optimization, and risk analytics capabilities into FlexTrade’s integrated...
Anglais

Dream Industrial REIT Announces Entry Into U.K. Multi-Let Industrial Market and Growth of Strategic Private Ventures in Europe

Dream Industrial Real Estate Investment Trust (TSX: DIR.UN) (the “Trust” or the “REIT” or “DIR”) today announced that the Trust and Dream Unlimited Corp. (TSX: DRM) (“Dream”), have entered into definitive agreements for Dream to acquire Chancerygate Limited (“Chancerygate” or “CG”), a U.K.-based industrial developer and asset manager...
Anglais